1-3 of 3
Aruna C. Gowda, MD
Close
Sort by
Journal Articles

Humanized Anti CD-40 Antibody SGN-40 Effectively Induces Cytotoxicity Against Chronic Lymphocytic Leukemia (CLL) Cells through Antibody Mediated Cytotoxicity and Demonstrates Modest Biologic Evidence of CD40 Activation.

Aruna C. Gowda, MD, Xiaobin B. Zhao, M.S, Carolyn Cheney, BS, Najma Mehter, BS, Gerard Lozanski, M.D, Thomas S. Lin, M.D PhD, Sara Guster, M.S, J. G. Drachman, M.D, Natarajan Muthusamy, DvM, PhD, John C. Byrd, M.D
Journal: Blood
Blood (2005) 106 (11): 2966.
https://doi.org/10.1182/blood.V106.11.2966.2966
Published: 2005
Journal Articles

Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Structural Changes in the Internal Domain of CD20 Regulated at the Post-Transcriptional Level.

Myron S. Czuczman, MD, Scott Olejniczak, BS, Aruna C. Gowda, MD, Petr Starostik, PhD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2004) 104 (11): 2280.
https://doi.org/10.1182/blood.V104.11.2280.2280
Published: 2004
Journal Articles

The Effects of Alemtuzumab (A) Dose-Sequence upon Rituximab (R)-Induced Reorganization of Lipid Raft Domains and In-Vitro/In Vivo Anti-Tumor Activity.

Francisco J. Hernandez-Ilizaliturri, MD, Aruna C. Gowda, MD, Dana Brombos, MS, Dan Spear, MS, Myron S. Czuczman, MD
Journal: Blood
Blood (2004) 104 (11): 2289.
https://doi.org/10.1182/blood.V104.11.2289.2289
Published: 2004